www.antimicrobe.org

[Start Page] [Microbes] [Antimicrobial Agents] [HIV Clinical Manual] [Feedback] [Logout]

Echinococcus species (Echinococcosis)

 

 

Read the Chapter

Sliding Table of Contents on the left of the screen

 

Vignettes

Tappe D, Frosch M.  Rudolf Virchow and the Recognition of Alveolar Echinococcosis, 1850s. Emerging Infectious Diseases 2007;13:732-735.

Tappe D.  Emergence of Polycystic Neotropical Echinococcosis. Emerg Infect Dis 2008;14(2):292-297.

Ebrahimi A, et al. Whole body bone scintigraphy in osseous hydatosis: a case report.  BMC Musculoskeletal Disorders.  2007;93:1752-1947.

Hegglin D, Deplazes P. Control strategy for Echinococcus multilocularis. Emerg Infect Dis. 2008 Oct;14:1626-8.

Review Article: Craig, PS, McManus, D., Lightowlers M., Chabalgoity, J., Garcia, H.,  Gavidia, C., Gilman, R., Gonzalez, A., Lorca, M., Naquira, C, Nieto, A., and Schantz, P. Prevention and Control of Cystic Echinococcosis. The LANCET Infectious Diseases. June 2007; Vol.7; 6: 385-394.

 

Tables and Figures

Table 1. Criteria for the Evaluation of Patients with Cystic Echinococcosis  

Table 2. Patient Response to Albendazole Treatment in Cystic Echinococcosis 

Table 3. Summary of Cyst Responses to Albendazole Treatment in Cystic Echinococcosi

Table 4. Effect of Treatment Duration on Albendazole Efficacy in Cystic Echinococcosis 

Table 5. Comparison of Efficacy of Albendazole & Mebendazole (Global Evaluation) of Patient Response

 Table 6. Comparison of Efficacy of Albendazole & Mebendazole (Cyst Evolution) of Patient Response

Table 7. Adverse Clinical Events and Fatal Events in Patients Treated with Albendazole for Various Reasons

 

 

Authors

Dominique Angèle Vuitton, MD, PhD,  Isabelle Beurton, M.D., Said Harraga, Ph.D. , Gilles Paintaud, M.D., Ph.D.

 

 

www.antimicrobe.org

[Start Page] [Microbes] [Antimicrobial Agents] [HIV Clinical Manual] [Feedback] [Logout]